10x Genomics (TXG) Tax Provisions (2018 - 2026)

10x Genomics (TXG) has 9 years of Tax Provisions data on file, last reported at $623000.0 in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions fell 26.88% year-over-year to $623000.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 6.19% YoY), and the FY2025 full-year result was $3.6 million, down 26.18% from the prior year.
• Tax Provisions eased to $623000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $2.5 million in Q2 2025 to a low of -$733000.0 in Q3 2025.
• A 5-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions jumped 259.27% in 2022 and tumbled 155.74% in 2025, its largest moves.
• Tracing TXG's Tax Provisions over 5 years: stood at $804000.0 in 2022, then surged by 192.79% to $2.4 million in 2023, then slumped by 72.47% to $648000.0 in 2024, then soared by 63.43% to $1.1 million in 2025, then slumped by 41.17% to $623000.0 in 2026.
• Business Quant data shows TXG's Tax Provisions at $623000.0 in Q1 2026, $1.1 million in Q4 2025, and -$733000.0 in Q3 2025.